Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2015 Aug 12;83(9):3342–3354. doi: 10.1128/IAI.00291-15

Tir Triggers Expression of CXCL1 in Enterocytes and Neutrophil Recruitment during Citrobacter rodentium Infection

Valerie F Crepin 1,✉, Maryam Habibzay 1, Izabela Glegola-Madejska 1, Marianne Guenot 1, James W Collins 1, Gad Frankel 1,✉
Editor: A J Bäumler
PMCID: PMC4534649  PMID: 26077760

Abstract

The hallmarks of enteropathogenic Escherichia coli (EPEC) infection are formation of attaching and effacing (A/E) lesions on mucosal surfaces and actin-rich pedestals on cultured cells, both of which are dependent on the type III secretion system effector Tir. Following translocation into cultured cells and clustering by intimin, Tir Y474 is phosphorylated, leading to recruitment of Nck, activation of N-WASP, and actin polymerization via the Arp2/3 complex. A secondary, weak, actin polymerization pathway is triggered via an NPY motif (Y454). Importantly, Y454 and Y474 play no role in A/E lesion formation on mucosal surfaces following infection with the EPEC-like mouse pathogen Citrobacter rodentium. In this study, we investigated the roles of Tir segments located upstream of Y451 and downstream of Y471 in C. rodentium colonization and A/E lesion formation. We also tested the role that Tir residues Y451 and Y471 play in host immune responses to C. rodentium infection. We found that deletion of amino acids 382 to 462 or 478 to 547 had no impact on the ability of Tir to mediate A/E lesion formation, although deletion of amino acids 478 to 547 affected Tir translocation. Examination of enterocytes isolated from infected mice revealed that a C. rodentium strain expressing Tir_Y451A/Y471A recruited significantly fewer neutrophils to the colon and triggered less colonic hyperplasia on day 14 postinfection than the wild-type strain. Consistently, enterocytes isolated from mice infected with C. rodentium expressing Tir_Y451A/Y471A expressed significantly less CXCL1. These result show that Tir-induced actin remodeling plays a direct role in modulation of immune responses to C. rodentium infection.

INTRODUCTION

Enteropathogenic Escherichia coli (EPEC) strains are important human pathogens causing infantile diarrhea in low-income countries (1) Recently, the Global Enteric Multicenter Study (GEMS), designed to detect the cause of pediatric diarrheal disease in sub-Saharan Africa and south Asia, found that infection with typical EPEC is associated with increased risk of fatality in infants aged 0 to 11 months (2). Citrobacter rodentium is a mouse-specific pathogen, the etiological agent of transmissible colonic hyperplasia, and a model EPEC microorganism, as both pathogens share an infection strategy and virulence factors (3, 4). Host resistance to C. rodentium infection is mediated by diverse T cell effector responses, including T cell production of interferon gamma (IFN-γ) (5, 6), interleukin 17A (IL-17A) (7, 8), or IL-22 (9). Expression of the proinflammatory cytokine IL-17A leads to recruitment of neutrophils (10), and the anti-inflammatory cytokine IL-22 upregulates expression of antimicrobial peptides (such as REGIIIβ and REGIIIγ) in enterocytes (9, 11).

While colonizing the gut mucosa, EPEC and C. rodentium induce attaching and effacing (A/E) lesions. These are characterized by extensive remodeling of the gut epithelium leading to elongation and effacement of the brush border (BB) microvilli, intimate bacterial attachment to the enterocyte apical plasma membrane, accumulation of polymerized actin, and formation of elevated pedestal-like structures (4, 12). Adhesion of EPEC (reviewed in reference 13) and C. rodentium (14) to cultured cells triggers actin polymerization under attached bacteria.

The ability to induce A/E lesions and actin polymerization is encoded within the locus of enterocyte effacement (LEE) (15), which encodes a type III secretion system (T3SS) (16), the outer membrane adhesin intimin (17), regulators, chaperones, and translocator and effector proteins (reviewed in reference 18). Following initial cell attachment, EPEC and C. rodentium use their T3SS to inject LEE- and non-LEE-encoded effectors that subvert multiple signaling pathways, including apoptosis (the effectors NleH and NleB), endosomal trafficking (EspG and EspI), Rho GTPases (EspH and Map), innate immunity (NleC, NleD, NleE, and NleF) and actin dynamics (Tir and EspF) (reviewed in reference 13). In particular, following translocation, Tir, which contains two transmembrane (TM) helixes, is integrated into the epithelial cell plasma membrane in a hairpin loop topology (19, 20), exposing an extracellular central domain that functions as an intimin receptor (21). Infection of cultured epithelial cells has shown that binding of intimin induces clustering of Tir, which leads to phosphorylation of a C-terminal tyrosine (20), Y474 in EPEC or Y471 in C. rodentium, by redundant tyrosine kinases, including Src, Fyn, and Abl (22, 23). These in turn recruit Nck via its SH2 domain, which activates the neural Wiskott-Aldrich syndrome protein (N-WASP) via its SH3 domain. This leads to recruitment of the Arp2/3 complex, which triggers actin polymerization underneath the attached bacteria (reviewed in reference 24). Campellone and Leong (25) have shown that TirEPEC can promote weak actin polymerization in an Nck-independent manner, involving the C-terminal Tir tyrosine residue Y454 (or Y451 in C. rodentium), which is present in the context of a conserved Asn-Pro-Tyr (NPY) motif (26). The NPY motif recruits the adaptor protein insulin receptor tyrosine kinase substrate (IRTKS) and/or the insulin receptor substrate protein of 53 kDa (IRSp53) (27, 28). In EPEC belonging to lineage 2, the weak Tir NPY-mediated actin polymerization pathway is amplified by the bacterial effector TccP2/EspFM, which also activates N-WASP (29).

Although it was widely believed that the Tir-induced actin signaling pathways observed during infection of cultured cells were responsible for A/E lesion formation on mucosal surfaces, Deng et al. (30) provided some initial indications that this might not be the case, as complementation of a tir C. rodentium mutant with a plasmid encoding Tir Y471F restored A/E lesion formation in vivo. Moreover, infection of human in vitro organ cultures (IVOC) with EPEC expressing Tir_Y474F or Tir_Y454F/Y474F also resulted in A/E lesions (31). In addition, we have subsequently reported that incorporation of Y451A and Y471A double substitutions into C. rodentium chromosomal tir abrogated actin polymerization in cultured cells but had no effect on the level of colonization and A/E lesion formation in the mouse model (14). Importantly, Ritchie et al. (32) and Mallick et al. (33, 34) have shown that A/E pathogens expressing tir mutants unable to trigger actin polymerization in vitro were attenuated in mucosal colonization in vivo. The aim of this study was to further investigate the role of the C terminus of Tir during C. rodentium infection in vivo.

MATERIALS AND METHODS

Bacterial strains and growth conditions.

The bacterial strains, plasmids, and primers used in this study are listed in Table 1. Bacteria were grown in Luria-Bertani (LB) medium, M9 minimum medium (35), or Dulbecco's modified Eagle's medium (DMEM) supplemented with kanamycin (50 mg ml−1), ampicillin (100 mg ml−1), and nalidixic acid (50 mg ml−1) as required.

TABLE 1.

Strains, plasmids, and primers used in this study

Strain, plasmid, or primer Description or nucleotide sequence Reference
Strains
    ICC169 Wild-type C. rodentium, O152 serotype 63
    ICC294 C. rodentium expressing TirC-ctrl 14
    ICC295 C. rodentium expressing Tir1-33stop 14
    ICC297 C. rodentium expressing Tir_Y451A 14
    ICC298 C. rodentium expressing Tir_Y471A 14
    ICC301 C. rodentium expressing Tir_Y451A/471A 14
    ICC1168 C. rodentium expressing Tir Δ382-462_Y471 This study
    ICC1169 C. rodentium expressing Tir Δ382-462_Y471A This study
    ICC1170 C. rodentium expressing Tir Δ478-547_Y451/Y471 This study
    ICC1171 C. rodentium expressing Tir Δ478-547_Y451A/Y471A This study
Plasmids
    pGEMT Cloning vector Promega
    pKD46 Plasmid coding for the lambda Red recombinase 36
    pSB315 Plasmid coding for the kanamycin resistance aphT cassette 64
    pICC433 pGEMT vector containing the 3′ end of tirCITRO (bp 1067–1644), the aphT cassette, the tir-cesT intergenic region, and the 5′ end of cesT (bp 1–388) 14
    pICC438 pICC433 containing tirCITRO Y451A/Y471A mutation 14
    pICC1842 pGEMT vector containing the 3′ end of tirCITRO (bp 1067–1434) from which amino acids 478–547 have been deleted, the aphT cassette, the tir-cesT intergenic region, and the 5′ end of cesT (bp 1–388) This study
    pICC1843 pICC1842 containing tirCITRO Y451A/Y471A mutation This study
    pICC1844 pGEMT vector containing the 3′ end of tirCITRO (bp 664–1644) from which amino acids 382–462 have been deleted, the aphT cassette, the tir-cesT intergenic region, and the 5′ end of cesT (bp 1–388) This study
    pICC1845 pICC1844 containing tirCITRO Y471A mutation This study
Primers
    Tir-P478DSV-stop-EcoRI-Rv 5′-CCGGAATTCTTAAACAGAATCAGGATCCGGAGCGACTTCATC-3′ This study
    down-Tir-EcoRI-Fw 5′-CCGGAATTCATATATAATGGGTATTTTGTTGGGGGGG-3′ This study
    Tir-down-TM2-Y471-Fw 5′-ATGCTCCATAGACGAAATTCGCTTCTCGCTCCAGAAGAG-3′ This study
    Tir-EcoRI-Rv 5′-CCGGAATTCTTAGACGAAACGTTCAACTCCC-3′ This study
    Tir-upTM1-Fw 5′-ACAACTTCAAGTGTTCGTTCAG-3′ This study
    Tir-down-TM2-Rv 5′-ATTTCGTCTATGGAGCATAGCC-3′ This study
    EcoRI-(tir-cesT)-Fw 5′-GATTATGTAATACCAGGTACAGG-3′ 14
    NcesT-Rv 5′-GCAGCCCTAGCATCACAAACAGACGGCGCGACAAG-3′ 14
    Tir-Up-YY-Fw 5′-TGGATCTCTCATCAGGTATTGG-3′ This study
    mCXCL1-F (KC-F) 5′-TGGCTGGGATTCACCTCAAGAACA-3′ 65
    mCXCL1-R (KC-R) 5′-TGTGGCTATGACTTCGGTTTGGGT-3′ 65
    mGAPDH-F 5′-TCAACAGCAACTCCCACTCTTCCA-3′ This study
    mGAPDH-R 5′-ACCCTGTTGCTGTAGCCGTATTCA-3′ This study

Introduction of site-directed tir mutations into the C. rodentium chromosome.

We used the lambda red-based mutagenesis system (36) to introduce site-directed tir alterations into the endogenous chromosomal tir gene, together with a kanamycin cassette, in the tir-cesT intergenic region for 3′ mutagenesis as described before (14).

Deletion of the DNA segment encoding amino acids 478 to 547 (Δ478-547) within the tir gene was made by inverse PCR on pICC433 (carrying Tir_Y451/Y471) and pICC438 (carrying Tir_Y451A/Y471A) templates, as previously described (14), using primer pair Tir-P478DSV-stop-EcoRI-Rv and down-Tir-EcoRI-Fw. The inverse-PCR product was then digested with EcoRI and the aphT gene cloned into the tir-cesT intergenic region to confer kanamycin resistance, resulting in plasmids pICC1842 and pICC1843, respectively (Table 1).

Deletion of the DNA segment encoding amino acids 382 to 462 (Δ382-462) within tir was made by overlapping PCR. C. rodentium genomic DNA was used to amplify tir base pairs 664 to 1164 using primer pair Tir-upTM1-Fw and Tir-down-TM2-Rv. The primer pair Tir-down-TM2-Y471-Fw and Tir-EcoRI-Rv was used to amplify tir base pairs 1383 to 1644 from pICC433 (carrying Tir_Y471) and pICC438 (carrying Tir_Y471A) templates. The two PCR fragments ([664-1164] and [1383-1644/Y471]) and ([664-1164] and [1383-1644/Y471A]) were PCR overlapped, EcoRI digested, and ligated to the tir-cesT intergenic region (PCR) amplified as previously described by Crepin et al. (14), using primers EcoRI-(tir-cesT)-Fw/NcesT-Rv. The ligated PCR product was then reamplified using primers Tir-upTM1-Fw and NcesT-Rv and cloned into pGEMT vector. The constructs were digested with EcoRI and the aphT gene cloned into the tir-cesT intergenic region to confer kanamycin resistance, resulting in plasmids pICC1844 and pICC1845, respectively (Table 1). All plasmid derivatives were checked by DNA sequencing.

The various deletions (Δ478-547_Y451/Y471 and Δ478-547_Y451A/Y471A; Δ382-462_Y471 and Δ382-462_Y471A) were PCR amplified from pICC1842 and pICC1843, using primers NcesT-Rv/Tir-Up-YY-Fw, and from pICC1844 and pICC1845, using primers NcesT-Rv/Tir-upTM1-Fw, respectively. The PCR products were electroporated into wild-type C. rodentium expressing the lambda red recombinase from plasmid pKD46 (36). The presence of the mutation was confirmed by PCR and DNA sequencing among the kanamycin-resistant clones.

Cell culture.

The Swiss 3T3 cell line was grown, maintained, and infected with the different C. rodentium strains at a multiplicity of infection (MOI) of 50, as described previously (14). Cells were washed at 6 h postinfection with phosphate-buffered saline (PBS), fixed for 15 min in 4% paraformaldehyde, and permeabilized with 0.1% Triton for 4 min. Phalloidin-tetramethyl rhodamine isocyanate (TRITC) (Sigma) was used to stain F actin, while bacterial DNA was counterstained with Hoechst 33342. Tir was stained using rabbit anti-Tir enterohemorrhagic E. coli (EHEC) (37, 38), recognizing the N-terminal domain, and carbocyanine-2-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Europe) secondary antibody. Images were acquired using an AxioCam MRm monochrome camera and processed using AxioVision (Carl Zeiss MicroImaging GmbH, Germany).

Tir translocation by C. rodentium was qualitatively assessed by calculating the ratio between the number of total visible bacterial nuclei and the number of bacteria which show Tir staining concentrated in a straight line at the interface between the bacteria. A minimum of 100 bacteria were counted per experiment, and the experiment was performed twice.

Oral infection of mice.

Pathogen-free female 18- to 20-g C57BL/6 mice were purchased from Charles River. All animals were housed in individually HEPA-filtered cages with sterile bedding and free access to sterilized food and water. All animal experiments were performed in accordance with the Animals Scientific Procedures Act (1986) and were approved by the local Ethical Review Committee. Infections were performed twice using four to eight mice per group. Mice inoculated with mock mutant and nonsense mutant strains were included in every experiment. Mice inoculated with the wild-type strain and uninfected mice were included in parallel with mutant strains.

Mice were inoculated by oral gavage with 200 μl of overnight LB-grown C. rodentium suspension in PBS (≈5 × 109 CFU). The number of viable bacteria used as inoculum was determined by retrospective plating onto LB agar containing antibiotics. Stool samples were recovered aseptically at various time points after inoculation, and the number of viable bacteria per gram of stool was determined by plating onto LB agar (39). At days 7 and 14 postinoculation, the mice were culled and the colonic tissues were collected for further analyses.

Sample collection and colonic crypt hyperplasia measurement.

Segments of the terminal colon (0.5 cm) of each mouse were collected, flushed, and fixed in 10% neutral buffered formalin. Formalin fixed tissues were then processed, paraffin-embedded, sectioned at 5 μm and stained with hematoxylin and eosin (H&E) using standard techniques. H&E-stained tissues were evaluated for colonic crypt hyperplasia microscopically without knowledge of the treatment condition used in the study, and the lengths of at least 20 well-oriented crypts from each section from all of the mice per treatment group (n = 4 to 6) were evaluated. H&E-stained tissues were imaged with an Axio Lab.A1 microscope (Carl Zeiss MicroImaging GmbH, Germany), and images were acquired using an Axio Cam ERc5s color camera and computer processed using AxioVision (Carl Zeiss MicroImaging GmbH, Germany).

Additional colonic segments were embedded in optimal cutting temperature (OCT) medium (Raymond A Lamb Limited, United Kingdom) and frozen in dry-ice/ethanol slush for further cryosectioning. Cryosections were then fixed in 3%-paraformaldehyde (PFA) in PBS as previously described (38, 40) and immunostained using primary antibodies at a 1/50 dilution: chicken anti-intimin (14), Ly-6G (RB6-8C5; Santa Cruz), and E-cadherin (CD324; BD Biosciences). Secondary antibodies were used at a 1/100 dilution: Cy3 (103-165-175; Jackson ImmunoResearch), Alexa 488 (712-546-150; Jackson ImmunoResearch), and Cy5 (715-175-150; Jackson ImmunoResearch), respectively. Images were acquired using an AxioCam MRm monochrome camera and processed using AxioVision (Carl Zeiss MicroImaging GmbH, Germany).

Extraction of enterocytes and immunostaining.

A 4-cm segment of the terminal colon was cut longitudinally, placed in 4 ml enterocyte dissociation buffer (1× Hanks' balanced salt solution without Mg and Ca containing 10 mM HEPES, 1 mM EDTA and 5 μl/ml 2-β-mercaptoethanol), and incubated at 37°C with shaking, for 40 min. Leftover tissue was removed by centrifugation (1,900 × g for 5 min) before the samples for each group were pooled and fixed with 1% formaldehyde. Fixed enterocytes (CD45− CD326+) were analyzed for purity by flow cytometry using leukocyte marker CD45 and epithelial cell marker CD326 (EpCAM). For immunofluorescence staining, fixed enterocytes were permeabilized with 0.1% Triton and blocked with 1% bovine serum albumin in PBS. Enterocytes were stained with polyclonal rabbit anti-Tir EHEC (GB1320, SK1786) for 20 min, followed by 30 min of incubation with secondary donkey anti-rabbit IgG(H+L) Alexa 488; phalloidin-TRITC (Sigma, P1951) was used for actin and DAPI (4′,6′-diamidino-2-phenylindole) (Invitrogen, D3571) to visualize the nucleus. Tir staining was visualized with an Axio Imager M1 microscope (Carl Zeiss MicroImaging GmbH, Germany), and images were acquired using an AxioCam MRm monochrome camera and computer processed using AxioVision (Carl Zeiss MicroImaging GmbH, Germany).

Isolation of mRNA and qRT-PCR.

mRNA of enterocytes was isolated using an RNeasy minikit according to the manufacturer's instructions (Qiagen). Samples were treated with RQ1 DNase I (Promega) at 37°C for 10 min, followed by 15 min at 72°C. Reverse transcription-PCR (RT-PCR) was carried out by adding Moloney murine leukemia virus (M-MLV) RT (Promega M170B), RT buffer (Promega), random primers (Promega), RNasin (Promega), deoxynucleoside triphosphates (dNTP) (10 mM), and RNase-free water to the DNase-treated RNA extract and incubating at 37°C for 1 h followed by 10 min at 72°C, and cooled samples were stored at −20°C. CXCL1 (KC) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs were amplified with primer pairs mCXCL1-F/mCXCL1-R and mGAPDH-F/mGAPDH-R (Table 1), by RT-quantitative PCR (qRT-PCR) using the 7300 Applied Biosystems instrument under standard cycle conditions for Fast SYBR green master mix. Changes in gene expression levels were analyzed relative to the control levels (PBS samples), with GAPDH as a standard, using the ΔΔCT method.

Sample collection for flow cytometry.

A 4-cm segment of the terminal colon was cut, opened longitudinally, rinsed in sterile PBS and placed in 4 ml of RPMI 1640 supplemented with 10% fetal bovine serum (FBS), penicillin-streptomycin (P/S), GlutaMAX, DNase (Roche, 10104159001), and liberase (Roche, 540112001) in a C-Mac tube (Miltenyi Biotec), followed by tissue dissociation using a gentleMACS dissociator (Miltenyi Biotec). The tissue was homogenized using the “intestine” setting, followed by incubation at 37°C with 5% CO2 for 30 min in a shaking incubator, and a final dissociation step was performed using the “lung 2” setting. The digested preparation was disrupted to a single-cell suspension by passage through a 70-μm sieve (BD Labware/Falcon, USA; catalog no. 352350) and suspended in RPMI 1640 supplemented with 10% FBS and P/S at 0.5 × 106 to 1 × 106 cells/ml.

Extracellular antigen analysis.

Cells were stained for surface markers as indicated in PBS containing 1% bovine serum albumin with 0.5% sodium azide (PBA) for 30 min at 4°C and fixed with IC fixation buffer (eBioscience). Prior to primary antibody staining, all cells were blocked for Fc receptors (FcR) using mouse FcR blocking reagent (Miltenyi Biotec) for 10 min at 4°C. Antibodies were purchased from BD Pharmingen or eBioscience. Data were acquired on a BD Fortessa III, and 20,000 lymphocytes or myeloid events were analyzed with the FlowJo (Tress Star) analysis program. Data are shown as a percentage of myeloid or lymphocyte gates. Myeloid and lymphocyte gates were determined by their position on the forward- and side-scatter plots generated by the cytometer. A fluorescence minus one (FMO) control was included for each fluorescent marker, and the expression of a particular marker was calculated by subtracting FMO fluorescence values from fluorescent-antibody levels.

Total live cells were assessed by trypan blue exclusion. Forward- and side-scatter gates on FlowJo software were used to gate myeloid cells, and the percentage of this gate was used to determine total number of myeloid cells. The myeloid cell gate was further analyzed to finalize the percentage of neutrophils (CD11b+ Ly6G+) and establish the total number of neutrophils in each mouse colon.

mIVOC.

The mouse intestinal in vitro organ culture (mIVOC) model was used to assess A/E lesion formation caused by C. rodentium expressing Tir Y451A/Y471A/Δ478-547 as described by Girard et al. (41). Briefly, segments from the terminal colon were inoculated with 50 μl of the appropriate overnight bacterial culture, corresponding to approximately 107 CFU, and incubated at 37°C in 5% CO2 atmosphere on a seesaw rocker (18 cycles min−1) for 8 h. Explants were gently rinsed with PBS and fixed in 2.5% glutaraldehyde for electron microscopy analysis.

Electron microscopy.

Additional explants/tissue cultured cell samples were processed for electron microscopy, as previously described (38). Samples for scanning electron microscopy (SEM) were examined at an accelerating voltage of 25 kV using a JEOL JSM-5300 scanning electron microscope [JEOL (UK) Ltd., Herts, United Kingdom]. Samples for transmission electron microscopy (TEM) were observed using a Phillips 201 transmission electron microscope at an accelerating voltage of 60 kV (Philips, United Kingdom).

Statistical analysis.

Results are presented as a line plot (colonization) with the mean and its standard deviation. The nonparametric Mann-Whitney test and the nonparametric Kruskal-Wallis test with Bonferroni's corrected a posteriori comparisons were used to conduct pairwise and global statistical analyses, respectively, using commercially available GraphPad InStat v3.06 software (GraphPad Software, San Diego, CA, USA). The Mann-Whitney test with comparison to PBS controls (or as indicated in the figure legends) was used for data obtained by flow cytometry using GraphPad Prism software. A P value of 0.05 was considered significant (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).

RESULTS

Construction of the 3′ tir chromosomal deletion mutants.

Previously, using a method that allows expression of tir mutants from the C. rodentium chromosome, we have introduced point mutations which have shown that A/E lesion formation in vivo is independent of Tir residues Y451 and Y471 (14). In this study, we used this technique to introduce deletions at the 3′ end of tir (Fig. 1). While inserting a kanamycin cassette coupled to the mutated tir into the tir-cesT intergenic region, we deleted Tir residues 382 to 462 (TirΔ382-462), removing the 80 amino acids downstream of the distal TM helix, and Tir residues 478 to 547 (TirΔ478-547), removing the entire segment downstream of Y471 phosphorylation site (Fig. 1). TirΔ382-462 was made in the context of either Y471 or Y471A (TirΔ382-462_Y471 and TirΔ382-462_Y471A), while TirΔ478-547 was made in the context of either Y451/Y471 or Y451A/Y471A (TirΔ478-547_Y451/Y471 and TirΔ478-547_Y451A/Y471A). As a positive control, we used a mock mutant tir-cesT (TirC-ctrl) in which the kanamycin cassettes was introduced into the intergenic region, which did not affect the tir coding sequence, and as a negative control, a nonsense codon was introduced at Tir position 33 (Tir1-33stop) (14). Growth curves in minimal and rich media confirmed that the mutants and parental wild-type strains had identical growth rates (data not shown).

FIG 1.

FIG 1

Schematic representing the different Tir variants used in this study. The two transmembrane helices, upstream and downstream of the intimin-binding domain, are represented as black boxes and include amino acids 231 to 257 and 360 to 382, respectively. Tyrosine residues Y451 and Y471 are shown in black and the substitutions Y451A and Y471A in gray. Deletions are represented as dashed lines.

Testing the carboxy-terminal Tir deletions during infection of cultured cells.

We characterized the behavior of the Tir derivatives in vitro, following infection of Swiss 3T3 fibroblast cells with the C. rodentium mutants as described before (14). This revealed that, as expected, C. rodentium expressing either TirΔ382-462_Y471A or TirΔ478-547_Y451A/Y471A failed to induce actin polymerization (data not shown). In contrast, infection of Swiss 3T3 cells with C. rodentium expressing TirΔ382-462_Y471 or TirΔ478-547_Y451/Y471 revealed robust actin polymerization under all the adherent bacteria that show Tir translocation (Fig. 2A). Importantly, while TirΔ382-462 was translocated as efficiently as the wild-type control Tir, TirΔ478-547 translocated with low efficiency, with Tir staining seen within 50% of the adherent bacteria (Fig. 2B). Interestingly, C. rodentium expressing TirΔ478-547_Y451/Y471 produced longer pedestals. These results suggest that Tir residues 382 to 462 are dispensable for Tir translocation and actin polymerization, while the carboxy terminus of Tir plays a role in translocation and hence indirectly in the efficiency (in terms of both frequency and length) of actin pedestals formed in vitro.

FIG 2.

FIG 2

(A) Immunofluorescence of Swiss 3T3 cells infected with C. rodentium. Tir (green) was detected under adherent C. rodentium expressing either TirC-ctrl, TirΔ382-462_Y451, or TirΔ478-547_Y451/Y471. Polymerized actin (red) was observed under Tir staining of all adherent bacteria. Bar, 5 μm. Infected cells were also analyzed by SEM (bar, 1 μm). (B) Tir translocation was qualitatively assess by determining the percentage of adherent bacteria showing translocated Tir staining. While C. rodentium expressing either TirC-ctrl or TirΔ382-462_Y451 showed no difference in Tir translocation efficiency, C. rodentium expressing TirΔ478-547_Y451/Y471 translocated Tir significantly less effectively.

Testing the carboxy-terminal Tir deletions during mouse infection.

We next investigated the impact of the C-terminal Tir deletions on colonization of C. rodentium in vivo by enumerating CFU per gram of stools (CFU g−1) collected daily following oral inoculation of C57BL/6 mice for 8 days. This showed that C. rodentium expressing either TirΔ382-462_Y471 or TirΔ382-462_Y471A colonized the mice similarly to the control strain expressing TirC-ctrl (Fig. 3A) (the variations between groups seen on day 2 postinfection are common during C. rodentium infection and do not have biological relevance; the differences seen on day 3 postinfection are not significant). Transmission electron microscopy (TEM) revealed typical A/E lesions in colons infected with C. rodentium expressing either TirΔ382-462_Y471 or TirΔ382-462_Y471A (Fig. 3B). In contrast, C. rodentium expressing Tir1-33stop was rapidly cleared and failed to initiate an infection, reaching the background level as soon as day 3 postinfection (Fig. 3A). These results show that the Tir segment from residue 382 to 462 is dispensable for colonization and that C. rodentium expressing TirΔ382-462_Y471 or TirΔ382-462_Y471A is capable of forming A/E lesions in vivo.

FIG 3.

FIG 3

(A) Colonization dynamics to the peak of C. rodentium infection (day8 postinfection). C57BL/6 mice inoculated with C. rodentium expressing TirC-ctrl, TirΔ382-462_Y451, or TirΔ382-462_Y451A exhibit similar colonization dynamics. Mice infected with C. rodentium expressing TirΔ478-547_Y451/Y471 or TirΔ478-547_Y451A/Y471A showed a reduced colonization compared to strains expressing TirC-ctrl, TirΔ382-462_Y451, or TirΔ382-462_Y451A. No difference was observed whether the Tir variants were made in the context of either Y451/Y471 or Y451A/Y471A. All strains colonized significantly better than C. rodentium expressing Tir1-33stop. (B) TEM and SEM of mice colonic epithelium infected with C. rodentium expressing TirC-ctrl, TirΔ382-462_Y451A, or TirΔ478-547_Y451A/Y471A. Local effacement of the brush border microvilli and intimately adherent bacteria (arrow), typical of A/E lesions, were observed following inoculation of mice with any of the C. rodentium strains. Intact brush border microvilli were observed in tissue extracted from uninfected mice.

We then tested the phenotype of C. rodentium expressing TirΔ478-547. Consistent with the in vitro data, this mutant exhibited an intermediate phenotype, reaching a colonization level of 106 CFU/g of stool on day 3 postinfection, which persisted at this level until day 8 (Fig. 3A). The level of colonization was 100-fold lower than that seen in mice infected with C. rodentium expressing TirC-ctrl or TirΔ382-462 but 104-fold higher than that in mice infected with Tir1-33stop. We observed no difference in colonization between mice infected with TirΔ478-547_Y451/Y471 or TirΔ478-547_Y451A/Y471A (Fig. 3A). However, as colonization was below the detection level of TEM, we performed a mouse IVOC infection using C. rodentium expressing TirΔ478-547_Y451A-Y471A. Examination of the samples by SEM revealed A/E lesions, similar to those formed by the wild-type strains, suggesting that the Tir segment from residue 478 to 547 is dispensable for A/E lesion formation on mucosal surfaces but does play a role in colonization (Fig. 3B), probably due to its role in Tir translocation.

Tir induces actin polymerization on enterocytes in vivo.

As the results thus far showed that C. rodentium expressing Tir deletions (residues 382 to 462 and 478 to 547) and substitutions (Y451 and Y471) was able to form A/E lesions, we tested whether Tir induced actin polymerization on enterocytes in vivo. For this, mice were infected with wild-type C. rodentium or C. rodentium expressing Tir_Y451A/Y471A (Fig. 1) and enterocytes were isolated at the peak of colonization at day 7 postinfection. Enterocytes isolated from naive mice as a control exhibited a typical “crown” staining pattern of the BB microvilli (Fig. 4). Enterocytes isolated from infected mice showed a good level of C. rodentium adhesion, with multiple bacteria on individual enterocytes. Tir was detected underneath both attached wild-type C. rodentium and C. rodentium expressing Tir_Y451A/Y471A (Fig. 4). However, while intense actin staining was seen at the site of wild-type C. rodentium infection, enterocytes infected with C. rodentium expressing Tir_Y451A/Y471A exhibited mainly weak actin polymerization at the site of bacterial attachment. This suggests that Tir induces actin polymerization on enterocytes in a process involving the tyrosine residues.

FIG 4.

FIG 4

Colonic enterocytes were isolated from mice infected with wild-type C. rodentium or C. rodentium expressing Tir_Y451A/Y471A at day 7 postinfection. Enterocytes isolated from uninfected mice were used as controls. Tir (green) was detected underneath attached C. rodentium bacteria; intense actin staining (red) was seen at the site of wild-type C. rodentium infection, while weak staining was observed at the attachment site of enterocytes infected with C. rodentium expressing Tir_Y451A/Y471A. Enterocytes isolated from uninfected mice showed typical brush border actin staining (arrow). Bar, 5 μm.

Recruitment of immune cells to the C. rodentium infection site.

As actin remodeling during infection can trigger immune responses (42), we next investigated whether Tir Y451 and Y471 modulate host immune responses. For this, groups of 4 to 6 mice were infected with wild-type and mutant C. rodentium, and recruitment of immune cells was analyzed by flow cytometry of homogenized colons at days 7 (peak of colonization) and day 14 (peak of pathology) postinfection. All the tested strains were shed at equivalent levels (Fig. 5A). The flow cytometry analysis showed that in comparison to the mock-infected (PBS) control mice (baseline readout), infection with either the wild type or mutant C. rodentium resulted in equivalent recruitment of macrophages, CD4+ T cells, and B cells on days 7 (data not shown) and 14 (Fig. 5B to D) postinfection. In contrast, significantly fewer neutrophils were recruited to the colon following infection with C. rodentium expressing Tir_Y451A/Y471A compared with the positive-control mice infected with C. rodentium expressing wild-type Tir or mice infected with the single Tir tyrosine mutants Y451A or Y471A (Fig. 5E and F). Similarly, although shedding was at equivalent levels (Fig. 5A), neutrophil recruitment was observed following infection with C. rodentium expressing TirΔ382-462_Y471 but not after infection with C. rodentium expressing TirΔ382-462_Y471A (Fig. 5G and H).

FIG 5.

FIG 5

(A) At day 14 postinfection, mice infected with C. rodentium expressing TirC-ctrl, Tir_Y451A, Tir_Y471A, Tir_Y451A/Y471A, TirΔ382-462_Y471, or TirΔ382-462_Y471A showed equivalent bacterial shedding. (B to D) Colonic tissues from mice infected with C. rodentium expressing TirC-ctrl, Tir_Y451A, Tir_Y471A, or Tir_Y451A/Y471A or from mock-infected mice (PBS) were harvested at 14 days postinfection and processed for fluorescence-activated cell sorter (FACS) analyses. No difference in recruitment of macrophages (CD11b+ Ly6G− F4/80+) (B), T helper cells (CD4+ CD8−) (C), and B cells (B220+ CD3−) (D) was observed in tissue infected with C. rodentium expressing the Tir variants. The results are from two independent experiments with 5 or 6 mice per group. (E and F) Neutrophil recruitment was significantly lower in tissue isolated from mice infected with C. rodentium expressing Tir_Y451A/Y471A than in that from mice infected with C. rodentium expressing wild-type Tir or a single tyrosine mutant. (G and H) Neutrophils were also analyzed in colonic tissue of mice infected with C. rodentium expressing either TirΔ382-462_Y471 or TirΔ382-462_Y471A. Reduced neutrophil recruitment was observed specifically in tissue infected with C. rodentium expressing TirΔ382-462_Y471A.

As C. rodentium and Tir interact mainly with enterocytes, we next determined whether the Tir tyrosine residues play a role in expression of proinflammatory chemokines. For this we isolated colonic enterocytes from mice infected with the different C. rodentium strains. The purity of the enterocyte preparation was confirmed by flow cytometry analysis following staining with the leukocyte marker CD45 and epithelial cell marker CD326 (EpCAM), revealing a low level of contamination (Fig. 6A). Using the purified enterocytes in qRT-PCR for the chemokines CXCL1 (KC) and CXCL2 (MIP2-alpha) revealed reduced expression in mice infected with C. rodentium expressing TirY451A-Y471A (Fig. 6B). The attenuated inflammatory responses triggered by C. rodentium expressing Tir_Y451A/Y471A were mirrored by a significantly reduced colonic hyperplasia (Fig. 7A and B) as well as neutrophil staining with Ly-6G antibodies (Fig. 7C). These results reveal a novel in vivo role for the Tir tyrosine residues TirY451 and Y471, which are also implicated in actin polymerization during C. rodentium infection (Fig. 4).

FIG 6.

FIG 6

(A) Enterocytes were isolated from colonic tissue of mice infected with C. rodentium or mock infected with PBS and assessed for purity using flow cytometry. Samples were stained for the leukocyte marker CD45 and the epithelial cell marker CD326 (EpCAM). Eighty to ninety percent of the cells were labeled CD326+ CD45−, which constituted the enterocyte population of the sample. (B and C) Enterocytes were isolated from colonic tissue of mice infected with C. rodentium expressing TirC-ctrl, Tir_Y451A, Tir_Y471A, or Tir_Y451A/Y471A, and the expression of the neutrophil chemoattractants CXCL1 (B) and CXCL2 (C) was measured by qRT-PCR (results are from two independent enterocyte isolation experiments; n = 4 per group). A reduced level of CXCL1 and CXCL2 mRNA was observed in tissue infected with C. rodentium expressing TirΔ382-462_Y471A. Data are presented relative to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and a PBS control.

FIG 7.

FIG 7

(A) Representative H&E section of colonic tissue from mice (n = 4) infected with C. rodentium expressing TirC-ctrl or Tir_Y451A/Y471A and mock-infected mice (PBS) at day 14 postinfection. (B) Measurements of crypt length reveal a significantly reduced level of colonic hyperplasia on day 14 postinfection in mice infected with C. rodentium expressing Tir_Y451A/Y471A compared to mice infected with C. rodentium expressing TirC-ctrl. (C) Frozen colonic sections were stained with antibodies against E-cadherin (tissue contrast) or Ly-6G (neutrophils) or with Hoechst stain (nuclei). Representative immunofluorescence shows more Ly-6G-positive neutrophil stain (pink) in colonic sections of mice infected with C. rodentium expressing TirC-ctrl than in mice infected with C. rodentium expressing Tir_Y451A/Y471A or the mock-infected control mice (PBS). Bars, 100 μm.

DISCUSSION

In this study, we found that C. rodentium expressing TirΔ382-462 colonized the mouse gastrointestinal tract and produced A/E lesions whether in the context of Y471 or Y471A. This result shows that amino acids 382 to 462 are dispensable for Tir activity. We also tested a chromosomal deletion of Tir residues 478 to 547. This has shown that C. rodentium expressing either TirΔ478-547_Y451/Y471 or TirΔ478-547_Y451A/Y471A behaved similarly, showing an colonization level intermediate between those for the wild-type and the Tir1-33stop strains. The fact that C. rodentium expressing either TirΔ478-547_Y451/Y471 or TirΔ478-547_Y451A/Y471A showed a 104-fold higher colonization level than mice infected with Tir1-33stop suggests that Tir is at least partially active. Due to the low level of colonization, we were unable to determine whether these strains could form A/E lesions in vivo using TEM, but we could confirm A/E lesions by SEM. A previous report demonstrated that a 6-amino-acid sequence (TYARLA) at positions 519 to 524 within the carboxy-terminal region was required for efficient secretion and translocation, but not for stability, of Tir-EHEC (43). The carboxy terminus of Tir C. rodentium contains an equivalent 6-amino-acid sequence (TYALLA), which is consistent with the low translocation efficiency seen by immunofluorescence staining following infection of Swiss 3T3 cells with C. rodentium expressing TirΔ478-547_Y451/471 and the intermediate in vivo phenotype of this strain.

Immunostaining of enterocytes isolated from naive mice revealed good preservation of the BB microvilli. In contrast, individual enterocytes isolated from infected mice were covered with adherent C. rodentium and exhibited effaced BB microvilli. Tir was detected at equivalent intensity at the site of bacterial attachment whether in the context of wild-type Tir or of Tir_Y451A/Y471A. Importantly, actin staining was considerably brighter under attached C. rodentium expressing wild-type Tir. This could potentially explain the competitive advantage of wild-type C. rodentium over C. rodentium expressing Tir_Y451A/Y471A during mixed infection (14). However, it is important to note that while, as expected, no Nck was recruited to C. rodentium expressing Tir_Y451A/Y471A in vivo (14) or to human intestinal biopsy specimens infected with EPEC expressing the Tir mutant (31), N-WASP was detected underneath the attached mutant strains, which could explain the faint actin polymerization seen in the enterocytes isolated from mice infected with C. rodentium expressing Tir_Y451A/Y471A. Taken together, these data suggest the existence of an as-yet-undetermined Tir actin polymerization pathway in mucosal surfaces.

If the Tir tyrosine residues do not play a role in A/E lesion formation, the question of what function they have during infection of mucosal surfaces remains. As EPEC and C. rodentium interact intermediately with enterocytes, we hypothesized that Tir-induced actin polymerization might contribute to signaling to the underlying immune system. To test this, we infected mice with C. rodentium expressing wild-type Tir and Tir tyrosine mutants and compared recruitment of immune cells in homogenized colons. This revealed no difference in recruitment of macrophages, T cells, or B cells at either 7 or 14 days postinfection. In contrast, a significantly reduced level of recruited neutrophils was seen at day 14 following infection with C. rodentium expressing Tir_Y451A/Y471A or TirΔ382-462_Y471A compared to infection with C. rodentium expressing wild-type Tir or TirΔ382-462_Y471. Moreover, mice infected with C. rodentium expressing Tir_Y451A/Y471A presented significantly reduced levels of colonic hyperplasia. Importantly, infection with C. rodentium expressing a single tyrosine Tir mutant (Y451A or Y471A) resulted in neutrophil recruitment equivalent to that seen following infection with wild-type C. rodentium. This phenotype was mirrored following testing for CXCL1 and CXCL2 expression by qRT-PCR on enterocytes purified from C. rodentium-infected mice. Similarly, it was previously reported that following EPEC infection, both Tir Y454 and Y474 are needed for efficient nuclear translocation of the transcription factor serum response factor (SRF) cofactor MAL and transcription of SRF target genes (44). CXCL1 and CXCL2 signal via CXCR2 to activate neutrophils and subsequently promote mucosal influx of neutrophils (45). Importantly, although neutrophils contribute to the host defense against infection (10), wild-type C. rodentium and C. rodentium expressing mutant Tir colonized at equivalent levels. These results suggest that while Tir contains redundant mechanisms leading to neutrophil recruitment, each relying on one of the two tyrosines, the host immune response can compensate for the lack of neutrophils late during infection and clear the pathogen.

Tir EPEC and C. rodentium have a further two distal tyrosines (Y480_Y508 and Y483_Y511, respectively) which comprise an immunoreceptor tyrosine-based inhibition motif (ITIM). Smith et al. (46) reported that following EPEC infection, Tir residues Y483 and Y511 recruit the host inositol phosphatase SHIP2. Moreover, the pedestals formed by EPEC expressing Tir Y483F_Y511F were significantly longer than those formed by EPEC expressing wild-type Tir, which is consistent with the longer pedestals that we observed following infection with C. rodentium expressing TirΔ478-547_Y451/Y471, which lacks residues Y480_Y508. Recently Yan et al. have shown that infection with EPEC expressing Tir Y483F_Y511F resulted in elevated levels of interleukin-6 (IL-6) and tumor necrosis factor (TNF) mRNAs in splenic cells and enhanced bacterial clearance (47). They have shown that phosphorylation of the Tir ITIM leads to the recruitment of both SHP1 and SHP2 and inhibition of TRAF6 autoubiquitination, which helps the bacteria to suppress and evade the host innate immune response (47, 48). This feature of Tir could provide an alternative explanation for why C. rodentium expressing TirΔ478-547_Y451/Y471 or TirΔ478-547_Y451A/Y471A did not colonize the colon at a wild-type level.

Subversion of the actin cytoskeleton by bacterial virulence factors has been shown to be an important mediator of immune signaling. For example, the Salmonella Rho GTPase GEF SopE has been shown to activate the pattern recognition receptors (PRRs) NOD1 (49), while NOD2 is regulated by Rac1 (50). NOD1 and NOD2, could be found at the plasma membrane in association with F actin, which is needed for downstream activation of NF-κB signaling (42, 51). Recently, Bielig et al. have shown that the actin depolymerization factor (ADF)/cofilin phosphatase SSH1 is an essential component of the NOD1 pathway, which plays a role in activation of NF-κB and cell responses to Shigella infection (52). Indeed, depletion of SSH1 mRNA resulted in reduced production of IL-8 and IL-6 following infection of HeLa cells with Shigella flexneri strain M90T. Consistently, our data show that sensing Tir-induced actin remodeling triggers host responses to C. rodentium infection.

C. rodentium translocates multiple effectors that contribute to coordinated cytoskeleton remodeling (including Map, which activates Cdc42 and Rac1 [53], EspM, which activates RhoA [54], EspT, which activates Rac1 [55] and EspJ, which inhibits Src kinases [56] that play a role in Tir tyrosine phosphorylation) and subversion of innate immune responses, including NF-κB (e.g., NleC, NleD, NleE, NleB, and NleF [13, 57–62]). Importantly, the difference in neutrophil recruitment seen at day 14 between wild-type C. rodentium and C. rodentium expressing Tir_Y451A/Y471A is at the time when both infections are close to being cleared. Future studies will aim at unraveling the mechanism by which Tir induces expression of CXCL1 and CXCL2 in enterocytes late during infection in the broader context of the other type III secreted effectors that modulate inflammatory responses.

ACKNOWLEDGMENT

This study was supported by a grant from the Wellcome Trust and the BBSRC.

REFERENCES

  • 1.Chen HD, Frankel G. 2005. Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev 29:83–98. doi: 10.1016/j.femsre.2004.07.002. [DOI] [PubMed] [Google Scholar]
  • 2.Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209–222. doi: 10.1016/S0140-6736(13)60844-2. [DOI] [PubMed] [Google Scholar]
  • 3.Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G. 2014. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol 12:612–623. doi: 10.1038/nrmicro3315. [DOI] [PubMed] [Google Scholar]
  • 4.Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. 2005. Citrobacter rodentium of mice and man. Cell Microbiol 7:1697–1706. doi: 10.1111/j.1462-5822.2005.00625.x. [DOI] [PubMed] [Google Scholar]
  • 5.Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT. 1999. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun 67:3031–3039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Shiomi H, Masuda A, Nishiumi S, Nishida M, Takagawa T, Shiomi Y, Kutsumi H, Blumberg RS, Azuma T, Yoshida M. 2010. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infect Immun 78:2653–2666. doi: 10.1128/IAI.01343-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH, Robertson SJ, Kim CJ, Kaul R, Philpott DJ, Girardin SE. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17:837–844. doi: 10.1038/nm.2391. [DOI] [PubMed] [Google Scholar]
  • 8.Cua DJ, Tato CM. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479–489. doi: 10.1038/nri2800. [DOI] [PubMed] [Google Scholar]
  • 9.Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289. doi: 10.1038/nm1720. [DOI] [PubMed] [Google Scholar]
  • 10.Spehlmann ME, Dann SM, Hruz P, Hanson E, McCole DF, Eckmann L. 2009. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immunol 183:3332–3343. doi: 10.4049/jimmunol.0900600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, Niess JH. 2013. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol 6:177–188. doi: 10.1038/mi.2012.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Knutton S, Lloyd DR, McNeish AS. 1987. Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun 55:69–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL. 2011. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 80:1420–1438. doi: 10.1111/j.1365-2958.2011.07661.x. [DOI] [PubMed] [Google Scholar]
  • 14.Crepin VF, Girard F, Schuller S, Phillips AD, Mousnier A, Frankel G. 2010. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo. Mol Microbiol 75:308–323. doi: 10.1111/j.1365-2958.2009.06938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 92:1664–1668. doi: 10.1073/pnas.92.5.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching-effacing lesions formation. Proc Natl Acad Sci U S A 92:7996–8000. doi: 10.1073/pnas.92.17.7996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87:7839–7843. doi: 10.1073/pnas.87.20.7839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Garmendia J, Frankel G, Crepin VF. 2005. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 73:2573–2585. doi: 10.1128/IAI.73.5.2573-2585.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hartland EL, Batchelor M, Delahay RM, Hale C, Matthews S, Dougan G, Knutton S, Connerton I, Frankel G. 1999. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol Microbiol 32:151–158. doi: 10.1046/j.1365-2958.1999.01338.x. [DOI] [PubMed] [Google Scholar]
  • 20.Kenny B. 1999. Phosphorylation of tyrosine 474 of the enteropathogenic Escherichia coli (EPEC) Tir receptor molecule is essential for actin nucleating activity and is preceded by additional host modifications. Mol Microbiol 31:1229–1241. doi: 10.1046/j.1365-2958.1999.01265.x. [DOI] [PubMed] [Google Scholar]
  • 21.Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511–520. doi: 10.1016/S0092-8674(00)80437-7. [DOI] [PubMed] [Google Scholar]
  • 22.Swimm A, Bommarius B, Li Y, Cheng D, Reeves P, Sherman M, Veach D, Bornmann W, Kalman D. 2004. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol Biol Cell 15:3520–3529. doi: 10.1091/mbc.E04-02-0093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Swimm A, Bommarius B, Reeves P, Sherman M, Kalman D. 2004. Complex kinase requirements for EPEC pedestal formation. Nat Cell Biol 6:795 (Author reply, 6: 795–796.) doi: 10.1038/ncb0904-795a. [DOI] [PubMed] [Google Scholar]
  • 24.Caron E, Crepin VF, Simpson N, Knutton S, Garmendia J, Frankel G. 2006. Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol 9:40–45. doi: 10.1016/j.mib.2005.12.008. [DOI] [PubMed] [Google Scholar]
  • 25.Campellone KG, Leong JM. 2005. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol Microbiol 56:416–432. doi: 10.1111/j.1365-2958.2005.04558.x. [DOI] [PubMed] [Google Scholar]
  • 26.Brady MJ, Campellone KG, Ghildiyal M, Leong JM. 2007. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway. Cell Microbiol 9:2242–2253. doi: 10.1111/j.1462-5822.2007.00954.x. [DOI] [PubMed] [Google Scholar]
  • 27.Vingadassalom D, Kazlauskas A, Skehan B, Cheng HC, Magoun L, Robbins D, Rosen MK, Saksela K, Leong JM. 2009. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A 106:6754–6759. doi: 10.1073/pnas.0809131106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Weiss SM, Ladwein M, Schmidt D, Ehinger J, Lommel S, Stading K, Beutling U, Disanza A, Frank R, Jansch L, Scita G, Gunzer F, Rottner K, Stradal TE. 2009. IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe 5:244–258. doi: 10.1016/j.chom.2009.02.003. [DOI] [PubMed] [Google Scholar]
  • 29.Whale AD, Hernandes RT, Ooka T, Beutin L, Schuller S, Garmendia J, Crowther L, Vieira MA, Ogura Y, Krause G, Phillips AD, Gomes TA, Hayashi T, Frankel G. 2007. TccP2-mediated subversion of actin dynamics by EPEC 2—a distinct evolutionary lineage of enteropathogenic Escherichia coli. Microbiology 153:1743–1755. doi: 10.1099/mic.0.2006/004325-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Deng W, Vallance BA, Li Y, Puente JL, Finlay BB. 2003. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 48:95–115. doi: 10.1046/j.1365-2958.2003.03429.x. [DOI] [PubMed] [Google Scholar]
  • 31.Schuller S, Chong Y, Lewin J, Kenny B, Frankel G, Phillips AD. 2007. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell Microbiol 9:1352–1364. doi: 10.1111/j.1462-5822.2006.00879.x. [DOI] [PubMed] [Google Scholar]
  • 32.Ritchie JM, Brady MJ, Riley KN, Ho TD, Campellone KG, Herman IM, Donohue-Rolfe A, Tzipori S, Waldor MK, Leong JM. 2008. EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7. Cell Microbiol 10:836–847. doi: 10.1111/j.1462-5822.2007.01087.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Mallick EM, Garber JJ, Vanguri VK, Balasubramanian S, Blood T, Clark S, Vingadassalom D, Louissaint C, McCormick B, Snapper SB, Leong JM. 2014. The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment. Cell Microbiol 16:1405–1424. doi: 10.1111/cmi.12302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Mallick EM, McBee ME, Vanguri VK, Melton-Celsa AR, Schlieper K, Karalius BJ, O'Brien AD, Butterton JR, Leong JM, Schauer DB. 2012. A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest 122:4012–4024. doi: 10.1172/JCI62746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mundy R, Petrovska L, Smollett K, Simpson N, Wilson RK, Yu J, Tu X, Rosenshine I, Clare S, Dougan G, Frankel G. 2004. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun 72:2288–2302. doi: 10.1128/IAI.72.4.2288-2302.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Batchelor M, Guignot J, Patel A, Cummings N, Cleary J, Knutton S, Holden DW, Connerton I, Frankel G. 2004. Involvement of the intermediate filament protein cytokeratin-18 in actin pedestal formation during EPEC infection. EMBO Rep 5:104–110. doi: 10.1038/sj.embor.7400038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Girard F, Dziva F, van Diemen P, Phillips AD, Stevens MP, Frankel G. 2007. Adherence of enterohemorrhagic Escherichia coli O157, O26, and O111 strains to bovine intestinal explants ex vivo. Appl Environ Microbiol 73:3084–3090. doi: 10.1128/AEM.02893-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wiles S, Dougan G, Frankel G. 2005. Emergence of a ‘hyperinfectious’ bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol 7:1163–1172. doi: 10.1111/j.1462-5822.2005.00544.x. [DOI] [PubMed] [Google Scholar]
  • 40.Girard F, Frankel G, Phillips AD, Cooley W, Weyer U, Dugdale AH, Woodward MJ, La Ragione RM. 2008. Interaction of enterohemorrhagic Escherichia coli O157:H7 with mouse intestinal mucosa. FEMS Microbiol Lett 283:196–202. doi: 10.1111/j.1574-6968.2008.01166.x. [DOI] [PubMed] [Google Scholar]
  • 41.Girard F, Crepin VF, Frankel G. 2009. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP. Infect Immun 77:1304–1314. doi: 10.1128/IAI.01351-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kufer TA, Kremmer E, Adam AC, Philpott DJ, Sansonetti PJ. 2008. The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 10:477–486. [DOI] [PubMed] [Google Scholar]
  • 43.Allen-Vercoe E, Toh MC, Waddell B, Ho H, DeVinney R. 2005. A carboxy-terminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion. FEMS Microbiol Lett 243:355–364. doi: 10.1016/j.femsle.2004.12.027. [DOI] [PubMed] [Google Scholar]
  • 44.Heath RJ, Leong JM, Visegrady B, Machesky LM, Xavier RJ. 2011. Bacterial and host determinants of MAL activation upon EPEC infection: the roles of Tir, ABRA, and FLRT3. PLoS Pathog 7:e1001332. doi: 10.1371/journal.ppat.1001332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–175. doi: 10.1038/nri3399. [DOI] [PubMed] [Google Scholar]
  • 46.Smith K, Humphreys D, Hume PJ, Koronakis V. 2010. Enteropathogenic Escherichia coli recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host Microbe 7:13–24. doi: 10.1016/j.chom.2009.12.004. [DOI] [PubMed] [Google Scholar]
  • 47.Yan D, Wang X, Luo L, Cao X, Ge B. 2012. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs. Nat Immunol 13:1063–1071. doi: 10.1038/ni.2417. [DOI] [PubMed] [Google Scholar]
  • 48.Yan D, Quan H, Wang L, Liu F, Liu H, Chen J, Cao X, Ge B. 2013. Enteropathogenic Escherichia coli Tir recruits cellular SHP-2 through ITIM motifs to suppress host immune response. Cell Signal 25:1887–1894. doi: 10.1016/j.cellsig.2013.05.020. [DOI] [PubMed] [Google Scholar]
  • 49.Keestra AM, Winter MG, Auburger JJ, Frassle SP, Xavier MN, Winter SE, Kim A, Poon V, Ravesloot MM, Waldenmaier JFT, Tsolis RM, Eigenheer RA, Baumler AJ. 2013. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496:233–237. doi: 10.1038/nature12025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Legrand-Poels S, Kustermans G, Bex F, Kremmer E, Kufer TA, Piette J. 2007. Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton. J Cell Sci 120:1299–1310. doi: 10.1242/jcs.03424. [DOI] [PubMed] [Google Scholar]
  • 51.Kufer TA. 2008. Signal transduction pathways used by NLR-type innate immune receptors. Mol Biosyst 4:380–386. doi: 10.1039/b718948f. [DOI] [PubMed] [Google Scholar]
  • 52.Bielig H, Lautz K, Braun PR, Menning M, Machuy N, Brugmann C, Barisic S, Eisler SA, Andree M, Zurek B, Kashkar H, Sansonetti PJ, Hausser A, Meyer TF, Kufer TA. 2014. The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling. PLoS Pathog 10:e1004351. doi: 10.1371/journal.ppat.1004351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Berger CN, Crepin VF, Jepson MA, Arbeloa A, Frankel G. 2009. The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics. Cell Microbiol 11:309–322. doi: 10.1111/j.1462-5822.2008.01254.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Arbeloa A, Garnett J, Lillington J, Bulgin RR, Berger CN, Lea SM, Matthews S, Frankel G. 2010. EspM2 is a RhoA guanine nucleotide exchange factor. Cell Microbiol 12:654–664. doi: 10.1111/j.1462-5822.2009.01423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Bulgin R, Arbeloa A, Goulding D, Dougan G, Crepin VF, Raymond B, Frankel G. 2009. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog 5:e1000683. doi: 10.1371/journal.ppat.1000683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Young JC, Clements A, Lang AE, Garnett JA, Munera D, Arbeloa A, Pearson J, Hartland EL, Matthews SJ, Mousnier A, Barry DJ, Way M, Schlosser A, Aktories K, Frankel G. 2014. The Escherichia coli effector EspJ blocks Src kinase activity via amidation and ADP ribosylation. Nat Commun 5:5887. doi: 10.1038/ncomms6887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Li S, Zhang L, Yao Q, Li L, Dong N, Rong J, Gao W, Ding X, Sun L, Chen X, Chen S, Shao F. 2013. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 501:242–246. doi: 10.1038/nature12436. [DOI] [PubMed] [Google Scholar]
  • 58.Pearson JS, Riedmaier P, Marches O, Frankel G, Hartland EL. 2011. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol Microbiol 80:219–230. doi: 10.1111/j.1365-2958.2011.07568.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TW, Mansell A, Riedmaier P, Oates CV, Zaid A, Muhlen S, Crepin VF, Marches O, Ang CS, Williamson NA, O'Reilly LA, Bankovacki A, Nachbur U, Infusini G, Webb AI, Silke J, Strasser A, Frankel G, Hartland EL. 2013. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 501:247–251. doi: 10.1038/nature12524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, Wagstaff KM, Dunstone MA, Sloan J, Whisstock JC, Kaper JB, Robins-Browne RM, Jans DA, Frankel G, Phillips AD, Coulson BS, Hartland EL. 2010. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 6:e1000898. doi: 10.1371/journal.ppat.1000898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Baruch K, Gur-Arie L, Nadler C, Koby S, Yerushalmi G, Ben-Neriah Y, Yogev O, Shaulian E, Guttman C, Zarivach R, Rosenshine I. 2011. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J 30:221–231. doi: 10.1038/emboj.2010.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Pallett MA, Berger CN, Pearson JS, Hartland EL, Frankel G. 2014. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-kappaB early during infection. Infect Immun 82:4878–4888. doi: 10.1128/IAI.02131-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Wiles S, Clare S, Harker J, Huett A, Young D, Dougan G, Frankel G. 2004. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 6:963–972. doi: 10.1111/j.1462-5822.2004.00414.x. [DOI] [PubMed] [Google Scholar]
  • 64.Galan JE, Ginocchio C, Costeas P. 1992. Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family. J Bacteriol 174:4338–4349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Raymond B, Crepin VF, Collins JW, Frankel G. 2011. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-kappaB-dependent manner. Cell Microbiol 13:1881–1893. doi: 10.1111/j.1462-5822.2011.01666.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES